374 related articles for article (PubMed ID: 22553111)
1. Highlights in antiviral drug research: antivirals at the horizon.
De Clercq E
Med Res Rev; 2013 Nov; 33(6):1215-48. PubMed ID: 22553111
[TBL] [Abstract][Full Text] [Related]
2. A cutting-edge view on the current state of antiviral drug development.
De Clercq E
Med Res Rev; 2013 Nov; 33(6):1249-77. PubMed ID: 23495004
[TBL] [Abstract][Full Text] [Related]
3. Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon.
Markland W; McQuaid TJ; Jain J; Kwong AD
Antimicrob Agents Chemother; 2000 Apr; 44(4):859-66. PubMed ID: 10722482
[TBL] [Abstract][Full Text] [Related]
4. Antiviral Activity Exerted by Natural Products against Human Viruses.
Musarra-Pizzo M; Pennisi R; Ben-Amor I; Mandalari G; Sciortino MT
Viruses; 2021 May; 13(5):. PubMed ID: 34064347
[TBL] [Abstract][Full Text] [Related]
5. The future of antivirals: broad-spectrum inhibitors.
Debing Y; Neyts J; Delang L
Curr Opin Infect Dis; 2015 Dec; 28(6):596-602. PubMed ID: 26524332
[TBL] [Abstract][Full Text] [Related]
6. Exploration of (hetero)aryl Derived Thienylchalcones for Antiviral and Anticancer Activities.
Patil V; Patil SA; Patil R; Bugarin A; Beaman K; Patil SA
Med Chem; 2019; 15(2):150-161. PubMed ID: 29792154
[TBL] [Abstract][Full Text] [Related]
7. Antiviral Strategies Using Natural Source-Derived Sulfated Polysaccharides in the Light of the COVID-19 Pandemic and Major Human Pathogenic Viruses.
Ray B; Ali I; Jana S; Mukherjee S; Pal S; Ray S; Schütz M; Marschall M
Viruses; 2021 Dec; 14(1):. PubMed ID: 35062238
[TBL] [Abstract][Full Text] [Related]
8. Broad-Spectrum Antiviral Entry Inhibition by Interfacially Active Peptides.
Hoffmann AR; Guha S; Wu E; Ghimire J; Wang Y; He J; Garry RF; Wimley WC
J Virol; 2020 Nov; 94(23):. PubMed ID: 32907984
[TBL] [Abstract][Full Text] [Related]
9. Drug Discovery of Nucleos(t)ide Antiviral Agents: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Birthday.
Li G; Yue T; Zhang P; Gu W; Gao LJ; Tan L
Molecules; 2021 Feb; 26(4):. PubMed ID: 33572409
[TBL] [Abstract][Full Text] [Related]
10. Antiviral Active Compounds Derived from Natural Sources against Herpes Simplex Viruses.
van de Sand L; Bormann M; Schmitz Y; Heilingloh CS; Witzke O; Krawczyk A
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372592
[TBL] [Abstract][Full Text] [Related]
11. 5-(Perylen-3-yl)ethynyl-arabino-uridine (aUY11), an arabino-based rigid amphipathic fusion inhibitor, targets virion envelope lipids to inhibit fusion of influenza virus, hepatitis C virus, and other enveloped viruses.
Colpitts CC; Ustinov AV; Epand RF; Epand RM; Korshun VA; Schang LM
J Virol; 2013 Apr; 87(7):3640-54. PubMed ID: 23283943
[TBL] [Abstract][Full Text] [Related]
12. Acyclic nucleoside phosphonates: past, present and future. Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridge.
De Clercq E
Biochem Pharmacol; 2007 Apr; 73(7):911-22. PubMed ID: 17045247
[TBL] [Abstract][Full Text] [Related]
13. Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry.
Lin LT; Chen TY; Lin SC; Chung CY; Lin TC; Wang GH; Anderson R; Lin CC; Richardson CD
BMC Microbiol; 2013 Aug; 13():187. PubMed ID: 23924316
[TBL] [Abstract][Full Text] [Related]
14. Favipiravir as a potential countermeasure against neglected and emerging RNA viruses.
Delang L; Abdelnabi R; Neyts J
Antiviral Res; 2018 May; 153():85-94. PubMed ID: 29524445
[TBL] [Abstract][Full Text] [Related]
15. Development of Broad-Spectrum Antiviral Agents-Inspiration from Immunomodulatory Natural Products.
Zhang M; Zhong J; Xiong Y; Song X; Li C; He Z
Viruses; 2021 Jun; 13(7):. PubMed ID: 34203182
[TBL] [Abstract][Full Text] [Related]
16. Human viral diseases: what is next for antiviral drug discovery?
De Clercq E
Curr Opin Virol; 2012 Oct; 2(5):572-9. PubMed ID: 22846888
[TBL] [Abstract][Full Text] [Related]
17. Broad-spectrum antivirals of protoporphyrins inhibit the entry of highly pathogenic emerging viruses.
Lu S; Pan X; Chen D; Xie X; Wu Y; Shang W; Jiang X; Sun Y; Fan S; He J
Bioorg Chem; 2021 Feb; 107():104619. PubMed ID: 33450541
[TBL] [Abstract][Full Text] [Related]
18. Curious discoveries in antiviral drug development: the role of serendipity.
De Clercq E
Med Res Rev; 2015 Jul; 35(4):698-719. PubMed ID: 25726922
[TBL] [Abstract][Full Text] [Related]
19. Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses.
Hu Y; Zhang J; Musharrafieh RG; Ma C; Hau R; Wang J
Antiviral Res; 2017 Sep; 145():103-113. PubMed ID: 28778830
[TBL] [Abstract][Full Text] [Related]
20. The rigid amphipathic fusion inhibitor dUY11 acts through photosensitization of viruses.
Vigant F; Hollmann A; Lee J; Santos NC; Jung ME; Lee B
J Virol; 2014 Feb; 88(3):1849-53. PubMed ID: 24284320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
